[1] PraneshN,TandonVK,KumarR, 1972.Herpes zoster: A clinical study,Indian J DermatolVenereolLeprol 38 152 -5
[2] SehgalVN,RegeVL,KharangateVN, 1976.The natural history of herpes zoster,Indian J DermatolVenereolLeprol 42 86 -9
[3] JohnsonRW,Alvarez-PasquinMJ,BijlM,FrancoE,GaillatJ,ClaraJG, 2015.Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective,Ther Adv Vaccines 3 109 -20
[4] ChaudharySD,PahwaDA, 1987.A clinicoepidemiologic profile of herpes zoster in North India, 53 213 -6
[5] RagozzinoMW,MeltonLJ,KurlandLT, 1982.Population based study of herpes zoster and its sequelae,Medicine (Baltimore) 6 310 -6
[6] SchmaderK,GeorgeLK,BurchettBM,PieperCF,HamiltonJD, 1995.Racial differences in the occurrence of herpes zoster,J Infect Dis 171 701 -4
[7] ThomasSL,HallAJ, 2004.What does epidemiology tell us about risk factors for herpes zoster,Lancet Infect Dis 4 26 -33
[8] JeonYH, 2015.Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment,Korean J Pain 28 177 -84
[9] HappenjansWB,BiblerMR,OrmeRL, 1990.Prolonged cutaneous herpes zoster in acquired immunodeficiency syndrome,Arch Dermatol 126 1048 -50
[10] BernhardP,ObelN., 1996.Chronic ulcerating acyclovir resistant varicella zoster lesions in an AIDS patient,Scand J Infect Dis 27 623 -5
[11] WatsonPN,EvensRJ, 1986.Postherpetic neuralgia: A review,Arch Neurol 43 836 -40
[12] 1996.Postherpetic neuralgia: Pathogenesis, treatment and prevention,N Engl J Med 335 32 -41
[13] 2011.Herpes zoster,Ann Intern Med 154 ITC31 -15
[14] TalwarS,ShrivastavaVK, 1991.Herpes zoster ophthalmicus with total ophthalmoplegia,Indian J DermatolVenereolLeprol 56 454 -5
[15] LiesegangTJ, 2008.Herpes zoster ophthalmicus,Ophthalmology 115 S3 -S12
[16] HutchinsonJ., 1942.A clinical report on herpes zoster ophthalmicus (shingles affecting the forehead and nose),Trans Am OphthalmolSoc 40 390 -439
[17] KarHK,GautamRK,JainRK, 1995.Disseminated cutaneous herpes zoster: A clinical predictor of human immunodeficiency virus infection,Indian J Dermatol Venereol Leprol 61 40 -1
[18] MandalBK, 2006.Herpes Zoster in the immunocompromised populations,Indian J Dermatol Venereol Leprol 51 235 -43
[19] FueyoMA,LookingbillDP, 1984.Herpes zoster and occult malignancy,J Am AcadDermatol 11 480 -2
[20] GohCL,Khoo L, 1997.A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic,Int J Dermatol 36 667 -72
[21] DubeyAK,JaisankarTJ,ThappaDM, 2005.Clinical and morphological characteristics of herpes zoster in south India,Indian J Dermatol 50 203 -7
[22] Abdul LatheefEN,PavithranK., 2011.Herpes zoster: A clinical study in 205 patients, 56 529 -32